ClinicalTrials.Veeva

Menu

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

U

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Status

Enrolling

Conditions

Renal Cell Carcinoma (Kidney Cancer)

Study type

Observational

Funder types

Other

Identifiers

NCT07118813
2025-0672

Details and patient eligibility

About

This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026;
  2. Aged > 18 years old;
  3. At least one abdominal CT scan before treatment;
  4. Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma.

Exclusion criteria

  1. Poor image quality;
  2. Incomplete clinical data or loss of follow-up;
  3. Presence of another primary malignancy other than renal cell carcinoma;
  4. Unclear pathological diagnosis.

Trial contacts and locations

1

Loading...

Central trial contact

Lian Yang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems